chartexchange

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

PR Newswire | Oct 23, 2026 4:05 PM EDT

Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), an innovation-driven biopharmaceutical company advancing new therapies that address significant unmet medical needs, announces...

Read original article